These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 32016954

  • 1. LncRNA TERC alleviates the progression of osteoporosis by absorbing miRNA-217 to upregulate RUNX2.
    Gao GC, Yang DW, Liu W.
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):526-534. PubMed ID: 32016954
    [Abstract] [Full Text] [Related]

  • 2. MiRNA-19a-3p alleviates the progression of osteoporosis by targeting HDAC4 to promote the osteogenic differentiation of hMSCs.
    Chen R, Qiu H, Tong Y, Liao F, Hu X, Qiu Y, Liao Y.
    Biochem Biophys Res Commun; 2019 Aug 27; 516(3):666-672. PubMed ID: 31248594
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Teriparatide alleviates osteoporosis by promoting osteogenic differentiation of hMSCs via miR-375/RUNX2 axis.
    Lei NB, Liang X, Wang P, Liu Q, Wang WG.
    Eur Rev Med Pharmacol Sci; 2019 Dec 27; 23(24):11043-11050. PubMed ID: 31858576
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. LncRNA XIXT promotes osteogenic differentiation of bone mesenchymal stem cells and alleviates osteoporosis progression by targeting miRNA-30a-5p.
    Zhang HL, Du XY, Dong QR.
    Eur Rev Med Pharmacol Sci; 2019 Oct 27; 23(20):8721-8729. PubMed ID: 31696458
    [Abstract] [Full Text] [Related]

  • 8. MiRNA-365a-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation via targeting RUNX2.
    Cheng F, Yang MM, Yang RH.
    Eur Rev Med Pharmacol Sci; 2019 Sep 27; 23(18):7766-7774. PubMed ID: 31599402
    [Abstract] [Full Text] [Related]

  • 9. LncRNA LINC00205 stimulates osteoporosis and contributes to spinal fracture through the regulation of the miR-26b-5p/KMT2C axis.
    Wang H, Xu W, Chen X, Mei X, Guo Z, Zhang J.
    BMC Musculoskelet Disord; 2023 Apr 04; 24(1):262. PubMed ID: 37016415
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-1286 inhibits osteogenic differentiation of mesenchymal stem cells to promote the progression of osteoporosis via regulating FZD4 expression.
    Zhou JG, Hua Y, Liu SW, Hu WQ, Qian R, Xiong L.
    Eur Rev Med Pharmacol Sci; 2020 Jan 04; 24(1):1-10. PubMed ID: 31957812
    [Abstract] [Full Text] [Related]

  • 11. MiRNA-27a-3p promotes osteogenic differentiation of human mesenchymal stem cells through targeting ATF3.
    Fu YC, Zhao SR, Zhu BH, Guo SS, Wang XX.
    Eur Rev Med Pharmacol Sci; 2019 Aug 04; 23(3 Suppl):73-80. PubMed ID: 31389577
    [Abstract] [Full Text] [Related]

  • 12. Long non-coding RNA telomerase RNA elements improve glucocorticoid-induced osteoporosis by EZH2 to regulate DKK1.
    Hu H, Guo X, Mu T, Song H.
    Int J Rheum Dis; 2023 Apr 04; 26(4):638-647. PubMed ID: 36789537
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-200a-3p accelerates the progression of osteoporosis by targeting glutaminase to inhibit osteogenic differentiation of bone marrow mesenchymal stem cells.
    Lv R, Pan X, Song L, Sun Q, Guo C, Zou S, Zhou Q.
    Biomed Pharmacother; 2019 Aug 04; 116():108960. PubMed ID: 31112871
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. LncRNA MSC-AS1 promotes osteogenic differentiation and alleviates osteoporosis through sponging microRNA-140-5p to upregulate BMP2.
    Zhang N, Hu X, He S, Ding W, Wang F, Zhao Y, Huang Z.
    Biochem Biophys Res Commun; 2019 Nov 19; 519(4):790-796. PubMed ID: 31551149
    [Abstract] [Full Text] [Related]

  • 16. Resveratrol alleviates osteoporosis through improving the osteogenic differentiation of bone marrow mesenchymal stem cells.
    Chen XH, Shi ZG, Lin HB, Wu F, Zheng F, Wu CF, Huang MW.
    Eur Rev Med Pharmacol Sci; 2019 Jul 19; 23(14):6352-6359. PubMed ID: 31364143
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of miR-339 promotes differentiation of BMSCs and alleviates osteoporosis by targeting DLX5.
    Zhou J, Nie H, Liu P, Wang Z, Yao B, Yang L.
    Eur Rev Med Pharmacol Sci; 2019 Jan 19; 23(1):29-36. PubMed ID: 30657543
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bone marrow stem cells-derived exosomes extracted from osteoporosis patients inhibit osteogenesis via microRNA-21/SMAD7.
    Jiang LB, Tian L, Zhang CG.
    Eur Rev Med Pharmacol Sci; 2018 Oct 19; 22(19):6221-6229. PubMed ID: 30338786
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.